Search

ENANTA PHARMACEUTICALS INC

Ouvert

SecteurSoins de santé

13.99 -0.07

Résumé

Variation du prix de l'action

24h

Actuel

Min

13.57

Max

14.65

Chiffres clés

By Trading Economics

Revenu

-6.4M

-20M

Ventes

-2.8M

14M

BPA

-0.67

Marge bénéficiaire

-135.81

Employés

120

EBITDA

-6.8M

-15M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+41.84% upside

Dividendes

By Acuity

Prochains Résultats

13 nov. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-27M

374M

Ouverture précédente

14.06

Clôture précédente

13.99

Sentiment de l'Actualité

By Acuity

71%

29%

311 / 340 Classement par Healthcare

ENANTA PHARMACEUTICALS INC Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

24 août 2026, 19:06 UTC

News

Enanta Pharmaceuticals is rising despite recent downgrades, remaining above its 20-day moving average. HC Wainwright maintains a "buy" rating with a $20 target.

21 août 2026, 19:41 UTC

Enanta Pharmaceuticals is trading higher, supported by gains in biotechnology stocks. The asset remains above its 20-day moving average during Friday's session.

20 août 2026, 19:31 UTC

Enanta Pharmaceuticals Inc. shares are lower today amid pressure on biotechnology stocks, continuing a decline since Wednesday's close. No specific news was identified.

18 août 2026, 19:16 UTC

Enanta Pharmaceuticals is trading higher today, supported by a rally in the Biotechnology sub-sector. Shares have gained since Monday's close.

17 août 2026, 20:06 UTC

Enanta Pharmaceuticals Inc shares are lower today, continuing a decline since Friday amid broader market weakness following a drop in U.S. retail sales.

14 août 2026, 20:06 UTC

Enanta Pharmaceuticals is trading lower amid mixed market sentiment following a reported decline in U.S. retail sales for July.

13 août 2026, 19:36 UTC

Enanta Pharmaceuticals Inc is trading higher, remaining above its 20-day moving average, despite no specific company news identified for the price movement.

11 août 2026, 20:06 UTC

Enanta Pharmaceuticals Inc shares are lower today, reflecting broader market declines. The stock reached a session low earlier but has since recovered slightly.

5 août 2026, 19:46 UTC

Enanta Pharmaceuticals Inc shares are lower, reflecting broader market sentiment amid disappointing ADP employment data showing a rise of only 44,000 jobs in July.

4 août 2026, 19:46 UTC

Enanta Pharmaceuticals Inc shares are higher, buoyed by a decline in crude oil prices that eases inflation concerns. No specific company news was identified.

3 août 2026, 19:23 UTC

Enanta Pharmaceuticals Inc shares are rising amid a broader market rally, supported by gains in major technology stocks and renewed investor confidence.

31 juil. 2026, 20:06 UTC

Enanta Pharmaceuticals Inc's shares are lower today, continuing a downward trend amid rising U.S. Treasury yields and crude oil prices. No specific news was identified.

30 juil. 2026, 19:45 UTC

Enanta Pharmaceuticals Inc. is advancing, supported by broader market gains. Earlier in the session, shares pulled back from a session high.

29 juil. 2026, 18:26 UTC

Enanta Pharmaceuticals Inc is declining in Wednesday's session, marking the seventh consecutive day of lower prices. No specific news has been identified to explain the movement.

28 juil. 2026, 20:06 UTC

Enanta Pharmaceuticals Inc is declining, marking five consecutive sessions lower. The stock peaked earlier but has since pulled back amid broader market pressures.

27 juil. 2026, 18:36 UTC

Enanta Pharmaceuticals Inc is higher today, building on Friday's momentum amid broader market dynamics following a decline in oil prices.

24 juil. 2026, 20:06 UTC

Enanta Pharmaceuticals Inc. shares are lower today, reversing from a recent trend of higher daily closes since Thursday's close.

21 juil. 2026, 19:31 UTC

Enanta Pharmaceuticals is rising during Tuesday's session, reflecting broader market strength and positive sentiment from recent earnings reports by General Motors and Novartis.

20 juil. 2026, 19:46 UTC

Enanta Pharmaceuticals Inc shares are lower today, continuing a decline since Friday's close. The stock has shown significant volatility during the session.

Comparaison

Variation de prix

ENANTA PHARMACEUTICALS INC prévision

Objectif de Prix

By TipRanks

41.84% hausse

Prévisions sur 12 Mois

Moyen 20 USD  41.84%

Haut 20 USD

Bas 20 USD

Basé sur 1 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

1 ratings

1

Achat

0

Maintien

0

Vente

Sentiment

By Acuity

311 / 340Classement par Soins de santé

Sentiment de l'Actualité

Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos ENANTA PHARMACEUTICALS INC

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; EDP-938 and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; and Glecaprevir, which is in the market for the treatment of chronic infection with hepatitis C virus or HCV. The company has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir. Enanta Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in Watertown, Massachusetts.
help-icon Live chat